Human Papilloma Virus Vaccination in Girls With Cystic Fibrosis (VACCIN-HPV-MUC2)

CompletedOBSERVATIONAL
Enrollment

81

Participants

Timeline

Start Date

December 17, 2018

Primary Completion Date

April 30, 2019

Study Completion Date

April 30, 2019

Conditions
Mucoviscidosis
Interventions
OTHER

Self administrated questionnaire

Questionnaires are distributed to patients with their parents during their visit to the CF center.

Trial Locations (7)

Unknown

Service Mucoviscidose, Pneumologie, Bron

Hôpital d'Estaing, Clermont-Ferrand

Pôle Couple / Enfant, Grenoble

CRCM, Hôpital Robert Debré, Paris

CRCM, Hôpital Trousseau, Paris

CRCM, Institut Necker Enfants Malade, Paris

Centre de Ressources et de Compétences de la Mucoviscidose Adultes, Pierre-Bénite

All Listed Sponsors
lead

Hospices Civils de Lyon

OTHER

NCT03653377 - Human Papilloma Virus Vaccination in Girls With Cystic Fibrosis (VACCIN-HPV-MUC2) | Biotech Hunter | Biotech Hunter